Predictive and AI-driven protein science at PepTalk 2027

Jan 18–21, 2027 Carlsbad, CA ~1k attendees Website

28 organizations at PepTalk 2027 present work in predictive and ai-driven protein science: 13 suppliers and service providers, 12 drug developers and 3 academic, government and non-profit bodies. Between them they bring 75 presentations to the program. Most represented: AstraZeneca (10 on the program), Genentech (10 on the program), Merck & Co. (8 on the program). As of Oct 17, 2026.

All 166 organizations at PepTalk 2027 →

Showing 1–6 of 28 organizations

Organization	PepTalk 2027 Attendance
AstraZeneca Cambridge, UK
astrazeneca.com Large pharma Global pharmaceutical company developing antibodies, multispecifics and antibody-drug conjugates across oncology, respiratory, immunology and rare diseases.	Chair Mon Jan 18 8:50am–9:00am Chairperson's Remarks SYMPOSIUM: Predictive Protein Production Talk Mon Jan 18 9:30am–10:00am In silico Developability Assessment of Single- and Dual-Chain Antibodies SYMPOSIUM: Display of Biologics Talk Mon Jan 18 11:45am–12:15pm Predictive Assembly and Purification Schema for Multispecific Biologics Using Integrated AI/ML and Experimental QC Workflows SYMPOSIUM: Predictive Protein Production Talk Tue Jan 19 11:20am–11:50am Modular Generation of Multispecific Antibodies Using Protein Trans-Splicing Multispecifics Engineering & Design Panel Tue Jan 19 11:50am–12:20pm Selecting the Optimal Multispecific Format: Engineering Strategies from Discovery to Development Multispecifics Engineering & Design · with Rondo Therapeutics, Xencor, Eli Lilly +2 more Chair Tue Jan 19 1:25pm–1:30pm Chairperson's Remarks Recombinant Protein Production - Part 1 Talk Wed Jan 20 11:10am–11:40am Lipidic Platforms for Delivery of Complex Membrane Proteins in Lead Generation Recombinant Protein Production - Part 1 Talk Wed Jan 20 2:30pm–3:00pm End-to-End Automation of Intact Mass Spectrometry QC for Integrated Purification and Quality Workflows in High-Throughput Biologics Production Tools for Purification and Quality Talk Thu Jan 21 9:10am–9:40am Fit-for-Purpose Antibody Purification: A Strategic Guide to Scale, Selection, and Automation Readiness Tools for Purification and Quality Talk Thu Jan 21 11:50am–12:20pm Improving Dual Targeting Selectivity in T Cell Engagers via Synapse-Gated and Affinity-Tuned Trispecific Antibody Design Emerging T Cell Engagers Talk Thu Jan 21 1:40pm–2:00pm Scaling the Start: High-Throughput Generation of Transfection-Ready DNA and Scalable Workflows for Rapid Antibody Production Recombinant Protein Production - Part 2 / Tools for Purification and Quality Talk Thu Jan 21 2:40pm–3:10pm Rational Antibody Engineering for Multiparameter Developability Enhancement Biophysical Methods and Models Panel Thu Jan 21 3:00pm–3:40pm Building Effective Cross-Functional Protein Production Teams Recombinant Protein Production - Part 2 / Tools for Purification and Quality · with Thomson Instrument Company, UCLA, BioMarin +1 more
Genentech South San Francisco, CA
gene.com Large pharma Roche Group biotechnology company discovering and developing antibody, peptide and other protein medicines.	Talk Mon Jan 18 10:00am–10:30am A Machine-Learning–Enabled Venom Peptide Platform for Rapid Drug Discovery SYMPOSIUM: Display of Biologics Talk Mon Jan 18 11:45am–12:15pm Development of LRRC15-Binding Disulfide-Constrained Peptides for PET Imaging of Cancer-Associated Fibroblasts SYMPOSIUM: Peptide Drug Hunting—From Emerging Technologies to Clinical Impact Talk Mon Jan 18 4:00pm–4:30pm Mirror-Image mRNA Display Uncovers Isoform-Selective D-Peptide Macrocycles Targeting a Cryptic KRAS Pocket SYMPOSIUM: Peptide Drug Hunting—From Emerging Technologies to Clinical Impact Panel Mon Jan 18 4:30pm–5:00pm Breaking Down Silos—Integrating Disciplines to Accelerate Peptide Drug Discovery SYMPOSIUM: Peptide Drug Hunting—From Emerging Technologies to Clinical Impact · with EPOC Scientific, University of Florida, University of Queensland +1 more Talk Tue Jan 19 11:20am–11:50am De novo Design of Miniprotein Cytokine Mimics Targeting IL4Ra by Combining Diffusion Models, MD Simulations, and Phage Display Automation in Protein Discovery / Peptide Discovery & Engineering Predictive and AI-driven protein science Talk Tue Jan 19 2:30pm–3:00pm Characterization of T Cell Engaging Bispecific Antibodies and Combination Therapies with a High-Throughput Multiparametric Automated Assay and Data Analysis Platform Automation in Protein Discovery Panel Tue Jan 19 5:45pm–6:05pm Women in AI Meet-Up Plenary · with Novo Nordisk Chair Wed Jan 20 8:15am–8:20am Chairperson's Remarks Peptide Discovery & Engineering Talk Wed Jan 20 9:35am–10:05am What Does the Future Hold for Antibody "Lab-in-the-Loop" Methods? Analytical Intelligence Talk Wed Jan 20 9:40am–10:05am Discovery and Characterization of Potent Macrocycle Inhibitors Peptide Discovery & Engineering Talk Wed Jan 20 3:00pm–3:30pm Overcoming in-Process Autolysis: A Robust Purification Strategy for Difficult-to-Purify Recombinant Peptidases Tools for Purification and Quality
Merck & Co. Rahway, NJ
merck.com Large pharma Global pharmaceutical company, called MSD outside the US and Canada, with biologics, vaccines and macrocyclic peptide research.	Talk Mon Jan 18 10:00am–10:30am When Execution is No Longer the Bottleneck: Reimagining Design of Experiments for Predictive, Data-Driven Protein Production SYMPOSIUM: Predictive Protein Production Talk Tue Jan 19 9:10am–9:40am Implementing Agentic AI and Autonomous Systems in Analytical Development Analytical Intelligence Talk Tue Jan 19 9:40am–10:10am Discovery of an NRAS Isoform and Activation-State-Selective Macrocyclic Peptide Automation in Protein Discovery / Peptide Discovery & Engineering Chair Wed Jan 20 8:30am–8:35am Chairperson's Remarks Analytical Intelligence Talk Wed Jan 20 11:10am–11:40am Modeling Stability to Support Biotherapeutics Development Analytical Intelligence Chair Wed Jan 20 2:25pm–2:30pm Chairperson's Remarks Tools for Purification and Quality Talk Wed Jan 20 3:00pm–3:30pm Investigation of Low Molecular Weight (LMW) Formation of a Multispecific Antibody by Protease Inhibitor Study Biophysical Methods and Models Talk Wed Jan 20 3:30pm–4:00pm Rapid Benchtop ¹H-NMR for Real-Time Monitoring of Purification Performance and Product Quality Tools for Purification and Quality Talk Thu Jan 21 11:50am–12:20pm Scaling Formulation Development with 384-Well ELISA for Stability, Potency, and Process Monitoring Tools for Purification and Quality Talk Thu Jan 21 2:55pm–3:20pm Enabling Oral and Parenteral GLP-1 Delivery through Biophysical and Molecular Characterizations Peptide Therapeutics: Emerging Modalities & Development
Eli Lilly Indianapolis, IN
lilly.com Large pharma Global pharmaceutical company with peptide, antibody and other medicines in diabetes, obesity, oncology, immunology and neuroscience.	Talk Tue Jan 19 11:50am–12:20pm From Data Silos to Shared Insights: Democratizing Data and AI for Accelerated Biotherapeutics Analytics and Decision Making Analytical Intelligence Panel Tue Jan 19 11:50am–12:20pm Selecting the Optimal Multispecific Format: Engineering Strategies from Discovery to Development Multispecifics Engineering & Design · with Rondo Therapeutics, AstraZeneca, Xencor +2 more Panel Tue Jan 19 4:55pm–5:25pm AI's Real Impact on Biologic Drug Discovery: The Honest Scorecard Plenary · with Novo Nordisk, Prescient Design, Generate Biomedicines Predictive and AI-driven protein science Panel Wed Jan 20 1:20pm–2:15pm Peptides at the Inflection Point: From Constrained Scaffolds to AI-Designed Clinical Candidates—Where is Peptide Therapeutics Headed? Plenary · with EPOC Scientific, Unnatural Products, Novo Nordisk +2 more Peptide discovery and developmentPredictive and AI-driven protein science Talk Wed Jan 20 5:40pm–6:10pm Predictive Accelerated Stability Studies: A Strategic Approach to Developing Oligonucleotide Therapeutics Biophysical Methods and Models
Pfizer New York, NY
pfizer.com Large pharma Global pharmaceutical company making medicines and vaccines, with in-house biologics discovery, protein engineering and protein production groups.	Talk Mon Jan 18 11:15am–11:45am Miniaturized Site-Specific Platform for Rapid Manufacturability Assessment of Biologic Candidates SYMPOSIUM: Predictive Protein Production Talk Wed Jan 20 8:35am–9:05am Engineering a p40/TL1A Bispecific Antibody for IBD: How Format Optimization Enabled Clinical Candidate Selection Multispecifics Engineering & Design Talk Wed Jan 20 11:40am–12:10pm Developing GPCR Production Workflows to Support DNA-Encoded Library Screening Recombinant Protein Production - Part 1
Novo Nordisk Bagsværd, Denmark
novonordisk.com Large pharma Danish pharmaceutical company known for insulin and GLP-1 peptide medicines for diabetes and obesity, with protein and peptide discovery research.	Chair Tue Jan 19 4:20pm–4:25pm Chairperson's Remarks Plenary Panel Tue Jan 19 4:55pm–5:25pm AI's Real Impact on Biologic Drug Discovery: The Honest Scorecard Plenary · with Prescient Design, Eli Lilly, Generate Biomedicines Predictive and AI-driven protein science Panel Tue Jan 19 5:45pm–6:05pm Women in AI Meet-Up Plenary · with Genentech Panel Wed Jan 20 1:20pm–2:15pm Peptides at the Inflection Point: From Constrained Scaffolds to AI-Designed Clinical Candidates—Where is Peptide Therapeutics Headed? Plenary · with EPOC Scientific, Unnatural Products, Chugai Pharmaceutical +2 more Peptide discovery and developmentPredictive and AI-driven protein science Talk Thu Jan 21 3:20pm–3:45pm From Molecule to Mucosa: Designing Better Peptide Delivery Systems Peptide Therapeutics: Emerging Modalities & Development